Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

23.72 +0.03 (+0.13%)
Streaming Delayed Price Updated: 9:56 AM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 485,919
Open 23.61
Bid (Size) 23.70 (1)
Ask (Size) 23.74 (3)
Prev. Close 23.69
Today's Range 23.52 - 23.96
52wk Range 18.92 - 81.73
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk Faces Headwinds: Competitive Pressures and Compounded Drugs Force Lowered Outlook
Copenhagen, Denmark – Novo Nordisk (NASDAQ: NVO), the pharmaceutical powerhouse synonymous with diabetes and obesity care, has significantly pared back its full-year sales and profit projections for... 
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback
One of them is already a leader in the market for weight management drugs, and the other could join this field. 
Via The Motley Fool
Topics ETFs

Performance

YTD
-42.3%
-42.3%
1 Month
-43.6%
-43.6%
3 Month
-10.3%
-10.3%
6 Month
-19.5%
-19.5%
1 Year
-64.6%
-64.6%

More News

Read More
Peering Into Viking Therapeutics's Recent Short Interest
Via Benzinga
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.
Via The Motley Fool
Viking Short Interest Hits 5-Year High After Weight-Loss Drug Stumble, But Retail Clings To Bullish Mood For Now
Via Stocktwits
Jim Cramer Expects Palantir To Reach New All-Time High
Via Benzinga
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Via The Motley Fool
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years
Via The Motley Fool
The Problem With Weight Loss Stocks
Via The Motley Fool
Topics Economy
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
Via The Motley Fool
Why Viking Therapeutics Stock Popped Nearly 4% Today
Via The Motley Fool
Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk)
Via The Motley Fool
Topics Economy World Trade
Why Is Viking Therapeutics Stock Crashing, and Is It a Buying Opportunity?
Via The Motley Fool
Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump
Via Investor's Business Daily
Viking Therapeutics: What's Next?
Via The Motley Fool
2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts
Via The Motley Fool
Benzinga Bulls And Bears: Sunrun, Newegg, Walmart — And Powell Offers Rate Cut Hope
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Here's Why Shares in Viking Therapeutics Crashed This Week
Via The Motley Fool
Market Brief: After Viking Therapeutics’ Results, Is Entera Bio the Oral Platform Play to Watch? (NASDAQ: ENTX)
Via AB Newswire
Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip?
Via The Motley Fool
Here's Why Viking Therapeutics Bounced Back Today
Via The Motley Fool
Under Pressure: Palantir and Viking Therapeutics Face Investor Scrutiny
Via MarketMinute
Topics Artificial Intelligence
Viking's 42% Plunge Splits Experts—A '$129 Strong Buy' Or 'Clearly Inferior' Drug?
Via Benzinga
Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns
Via MarketMinute

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 23.72
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 09/17/25 09:56 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.36B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.